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Abstract 
Monoclonal antibodies recognizing the mitochondrially encoded subunits I and II, and the nuclear-encoded subunits IV, Va, Vb and 
VIc of human cytochrome-c oxidase were generated. These antibodies are highly specific and allow the assessment of subunit steady-state 
levels in crude cell extracts and tissue sections. In the experimental human cell line 143B206, which is devoid of mitochondrial DNA, 
immunovisualization with the antibodies revealed that the nuclear-encoded subunits IV and Va were present in amounts close to that of 
the parental cell line despite the absence of the mitochondrially encoded subunits. In contrast, the nuclear-encoded subunits Vb and VIc 
were severely reduced in cell line 143B206, suggesting that unassembled nuclear-encoded subunits are degraded at different rates. In 
skeletal muscle sections of a patient with chronic progressive xternal ophthalmoplegia known to harbor the 'common deletion' in a 
subpopulation f her mitochondrial DNA, most cytochrome-c oxidase activity negative fibers had greatly reduced levels of subunits I, II, 
Va, Vb and VIc of cytochrome-c oxidase. The steady-state level of subunit IV, however, was less affected. This was particularly evident 
in cytochrome-c oxidase activity negative fibers with accumulated mitochondria ('ragged-red' fibers) where immunodetection with 
anti-subunit IV resulted in intense staining. The data presented in this paper demonstrate that the battery of monoclonal antibodies can be 
employed for diagnostic purposes to analyze steady-state l vels of mitochondrially and nuclear-encoded subunits of cytochrome-c 
oxidase. 
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1. Introduction 
Mitochondria play a central role in cellular energy 
provision by the process of oxidative phosphorylation. In
this metabolic pathway, mitochondria generate ATP driven 
by a transmembrane proton gradient across the mitochon- 
drial inner membrane. The proton gradient is sustained by 
the respiratory chain which couples electron transfer from 
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NADH and FADH 2 to molecular oxygen with proton 
pumping across the membrane. The respiratory chain is 
comprised of four multisubunit enzyme complexes: 
NADH:ub iqu inone  ox idoreductase  (EC 1.6.5.3), 
succinate:ubiquinone oxidoreductase (EC 1.3.5.1), 
ubiquinol:ferricytochrome-c oxidoreductase (EC 1.10.2.2) 
and ferrocytochrome-c:oxygen oxidoreductase (cyto- 
chrome-c oxidase, EC 1.9.3.1) [1]. All subunits of succi- 
nate:ubiquinone oxidoreductase are encoded on nuclear 
DNA but some subunits of the other complexes are en- 
coded on mitochondrial DNA [2]. 
Cytochrome-c oxidase deficiency is emerging as one of 
the most common defects in mitochondrial diseases. In 
mammals, this enzyme is composed of three mitochon- 
drially encoded polypeptides (I, II and III) and ten 
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nuclear-encoded polypeptides (IV, Va, Vb, Via, VIb, VIc, 
VIIa, VIIb, VIIc and VIII). The mitochondrially encoded 
subunits are homologous to the three polypeptides found in 
bacterial cytochrome-c oxidases and constitute the cat- 
alytic core of the enzyme (for recent reviews see Refs. 
[3-5]). The function(s) of the nuclear-encoded subunits is 
enigmatic, although recent observations have clarified the 
role of one of these subunits. Kadenbach was the first to 
postulate that some of the nuclear-encoded subunits are 
involved in allosteric modification of cytochrome-c oxi- 
dase activity [6,7]. Support for this idea is provided by the 
presence of tissue and developmental specific isoforms of 
some of the nuclear-coded subunits (reviewed in Ref. [8]) 
which could optimize the enzymatic activity to the 
metabolic demands of different tissues. Recently, we 
demonstrated in yeast hat subunit Via, which is expressed 
as isoforms in mammals, contains an ATP binding site and 
inhibits the electron transfer activity in response to high 
physiological concentrations of ATP [9]. 
The dual genetic origin and isoform complexity of the 
enzyme may explain the remarkable clinical and biochemi- 
cal heterogeneity of cytochrome-c oxidase deficiencies, 
with different tissues being critically affected and with 
variable onset of symptoms (reviewed in Refs. [10-12]). 
With the exception of one patient with a 15-bp deletion in 
the gene for cytochrome-c oxidase subunit III [13], no 
molecular abnormality of any subunit of cytochrome-c 
oxidase has been shown to be associated with cytochrome-c 
oxidase deficiency. Partial defects of cytochrome-c oxi- 
dase activity, frequently accompanied by other respiratory 
chain abnormalities, are often associated with specific 
point mutations in tRNA genes or deletions in a subpopu- 
lation of the mitochondrial DNA (reviewed in Refs. [14- 
16]). For instance, in patients with ocular myopathy as a 
key feature, as in chronic progressive xternal ophthalmo- 
plegia (CPEO) and Kearns-Sayre syndrome, the focal de- 
fect of cytochrome-c oxidase in individual muscle fibers 
has been attributed to large-scale deletions or duplications 
in mitochondrial DNA. Reported deletions range in size 
but a deletion 'hotspot' between two 13-bp direct repeats 
results in the most common 5-kb deletion. This deletion 
includes the genes for subunit III of cytochrome-c oxidase, 
subunits 3, 4, 4L and 5 of the NADH:ubiquinone oxido- 
reductase complex and several unique tRNAs. A character- 
istic feature in these patients is a subsarcolemmal accumu- 
lation of morphologically abnormal mitochondria in mus- 
cle fiber sections, visualized as 'ragged-red fibers' with 
modified Gomori trichrome stain. 
Diagnosis of cytochrome-c oxidase deficiency is gener- 
ally made by histochemical nd biochemical analysis of 
the tissue involved, in concert with an analysis of mito- 
chondrial DNA. Recently, we described the development 
of antibodies against subunit isoforms to study 
Mendelian-inherited, tissue specific deficiencies of cy- 
tocbrome-c oxidase [17]. Here, we report he development 
of monoclonal antibodies against other nuclear and mito- 
chondrially encoded subunits of the enzyme to further 
dissect the various forms of cytochrome-c oxidase defi- 
ciency at the protein level. 
2. Materials and methods 
2.1. Cytochrome-c  oxidase 
Human heart cytochrome-c oxidase was isolated in the 
laboratory of Dr. A.O. Muijsers (E.C. Slater Institute for 
Biochemical Research, Academic Medical Center, Univer- 
sity of Amsterdam) according to published procedures 
[18]. The enzyme was dissociated in 3% (w/v)  sodium 
dodecyl sulfate (SDS) and subunits were resolved on 
standard gelfiltration columns [19]. To remove excess of 
SDS, subunits I and II were precipitated by addition of 3 
volumes of ethanol at room temperature. The protein pellet 
was washed with 80% (v/v)  ethanol, dried, and dissolved 
in phosphate-buffered saline (PBS), 0.1% (w/v) SDS for 
immunization. 
Bovine heart cytochrome-c oxidase was purified as 
described [20] and stored in small aliquots at -70°C until 
used for preparation of monoclonal antibodies against he 
nuclear-encoded subunits. To isolate single subunits, the 
enzyme was resolved on SDS-polyacrylamide g ls [21] 
followed by electro-elution f subunits in 10 mM Tris-HCl 
(pH 8.6), 0.1% (w/v)  SDS using an ISCO Electrophoretic 
Concentrator. 
2.2. Ant ibodies  
Table 1 lists the immunogen, mouse strain and myeloma 
cell line used to make each hybridoma. In each case, mice 
were immunized intraperitoneally with immunogen (either 
50 /zg holo-enzyme or 10 /xg isolated subunit) emulsified 
in Complete Freund's Adjuvant and then boosted intraperi- 
toneally at monthly intervals with immunogen in Incom- 
plete Freund's Adjuvant until high titers of specific anti- 
body were identified with immunoblots. Final boosts of 
immunogen i  saline were then delivered intraperitoneally 
at 4 and 3 days prior to splenocyte collection. Hybridoma 
cell lines were produced and cultured as previously de- 
scribed [22]. Standard HAT (hypoxanthine, aminopterin 
and thymidine) selection was used to select BALBc/GN 
+ P3X63-Ag8.653 hybridomas and BALBc/GN + SP2/0 
hybridomas, whereas AAT (adenine, aminopterin and 
thymidine) selection [23] was used to select RBF/DnJ + 
FOX-NY hybridomas. Myeloma cell lines were obtained 
from the American Type Culture Collection. 
Hybridoma supernatants were screened for anti-cyto- 
chrome-c oxidase antibodies using solid phase binding 
assays with native holo-cytochrome-c oxidase of the ap- 
propriate species as target antigen [17]. Antibody binding 
specificities were further characterized by immunoblot 
analysis [8] of cytochrome-c oxidase or mitochondria from 
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various species. The specificities of the monoclonal anti- 
bodies against subunit Va and Vb (6E9-B 12-D5 and 16H12, 
respectively) were checked on immunoblots with bovine 
cytochrome-c oxidase separated on a polyacrylamide gel 
(16.5% T, 6% C) containing 6 M urea, under the condi- 
tions described by Sch~igger and Von Jagow [24]. On this 
gel system, subunit Va and Vb switch in position com- 
pared to their location on the gel system described by 
Kadenbach et al. [21]. The specificity of the monoclonal 
antibody against subunit VIc (3G5-F7-G3) was determined 
on immunoblots with isolated subunit VIb and bovine 
cytochrome-c oxidase extracted with Triton X-100. Treat- 
ment of the enzyme with this detergent removes ubunit 
VIb (Y.-Z. Zhang and R.A. Capaldi, unpublished observa- 
tions, [25]) which co-migrates with subunit VIc on SDS- 
polyacrylamide gels. 
Monoclonal antibodies were purified from serum-free 
hybridoma culture supernatants a  described by Marusich 
et al. [26], or used as untreated cell culture supernatants. 
The development of monoclonal antibodies specific for 
bovine (and human) cytochrome-c oxidase subunit IV has 
previously been described [17]. Monoclonal antibodies 
against subunits I, II, IV and VIc have been made gener- 
ally available (Molecular Probes, Inc,). 
2.3. Immunoblot  analysis 
The cell line 143B206 [27], which has been completely 
depleted of mitochondrial DNA (p°  cells) by long-term 
exposure to ethidium bromide, and the parental osteosar- 
coma cell line 143B - TK-  were kindly provided by Dr. G. 
Attardi (Division of Biology, California Institute of Tech- 
nology, Pasadena, CA). Cells were lysed in 5% (w/v)  
SDS. Protein concentrations were determined according to 
Smith et al. [28] with the bicinchoninic acid kit (Pierce) 
using bovine serum albumin as standard. Similar amounts 
of protein from the two cell lines were resolved on 5.5 M 
urea, 10-20% polyacrylamide gradient minigels [29], blot- 
ted onto poly(vinylidene difluoride) (PVDF) membranes 
(Millipore), and strips of the immunoblots were incubated 
with antibodies (ID6-E1-A8 and 5D4-F5, 1 /xg IgG/ml;  
12C4-F12, 0.1 /.~g IgG/ml;  10G8-D12-C12 and 6E9-B12- 
D5, 2 /zg IgG/ml;  16H12, 50 /zl culture medium/ml; 
3G5-F7-G3, 5 /zg IgG/ml)  and developed using the 5- 
bromo-4-chloro-3-indolyl phosphate and nitro blue tetra- 
zolium-alkaline phosphatase r action as described [8]. 
2.4. H is tochemist~ and immunohistochemist~' 
Patient and age-matched control skeletal muscle speci- 
mens, obtained by open biopsy, were immediately frozen 
in liquid nitrogen-cooled isopentane and stored at -70°C. 
The patient suffered chronic progressive xternal ophthal- 
moplegia (CPEO) and was known to carry the 'common' 
5-kb mitochondrial DNA deletion in a relatively high 
percentage of her skeletal muscle mitochondrial DNA. The 
samples were obtained, with permission, following proto- 
cols approved by the OHSU Human Studies Committee. 
Muscle sections (8 /zm thick) were mounted on poly-L- 
lysine coated slides. Demonstration of the activity of cy- 
tochrome-c oxidase and succinate dehydrogenase were 
performed as described [30,31]. Fiber type was determined 
by myofibrillar actomyosin ATPase staining at pH 9.4 
after preincubation at pH 4.5 [32]. Ragged-red fibers were 
stained with modified Gomori trichrome [33]. 
Muscle sections (8 /zm thick) used for all immuno- 
staining studies were air-dried, followed by fixation for 5 
min in 4% (v/v)  methanol-free formaldehyde, 0.1 mM 
CaCl 2, 0.1 M sodium phosphate buffer (pH 7.2). Prior to 
immunostaining, the sections were treated with 0.6% (v/v)  
H20 2 in 80% (v/v)  methanol for 30 min at room tempera- 
ture. Sections were pre-incubated in PBS supplemented 
with 1% (w/v)  bovine serum albumin for 10 rain at room 
temperature. Sections were then incubated for 2 h in PBS, 
1% (w/v)  bovine serum albumin, containing primary anti- 
bodies. Primary antibodies were used at dilutions opti- 
mized to give consistent immunostaining in all fibers of 
the control muscle sections. Following subsequent incuba- 
tion with biotinylated anti-mouse immunoglobulins (Vec- 
tor Laboratories) for 1 h and incubation with avidin-bio- 
tinylated horseradish peroxidase complex (Vectastain ABC 
kit, Vector Laboratories) for 1 h, sections were reacted 
with 3,3'-diaminobenzidine (Sigma) in PBS. Controls in- 
cluded a 2-h incubation in PBS, 1% (w/v)  bovine serum 
albumin, without primary antibody. 
Table l 
Anti-cytochrome-c oxidase monoclonal ntibodies 
Subunit binding Immunogen Hybridoma Isotype Mouse strain Myeloma cell line 
specificity 
Subunit I human subunit I l D6-E l-A8 IgG2a ~¢ RBF/DnJ FOX-NY 
Subunit I human subunit I 5D4-F5 IgG2aK RBF/DnJ FOX-NY 
Subunit II human subunit II ! 2C4-F12 IgG2a ~c RBF/DnJ FOX-NY 
Subnnit IV bovine holo-enzyme ~ 10G8-D12-CI2 IgG2aK BALBc/GN P3X63-Ag8.653 
Subunit Va bovine subunit Va 6E9-B 12-D5 IgG2a K BALBc/GN SP2/0 
Subunit Vb bovine holo-enzyme 16H 12 IgG2bK BALBc/GN P3X63-Ag8.653 
Subunit VIc bovine holo-enzyme 3G5-F7-G3 IgG2bK BALBc/GN P3X63-Ag8.653 
d Bovine subunit IV in final boost. 
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Fig. 1. Immunoblot analysis of monoclonal ntibodies against cytochrome-c oxidase subunits. Immunoblot strips with total cellular protein (25 /xg/strip) 
of the human control cell line 143B. TK- (c) and its derivative cell line 143B206 (p0) were exposed to the monoclonals: 5D4-F5 (I-1), 1D6-E1-A8 (I-2), 
12C4-F12 (II), 10G8-C12-DI2 (IV), 6E9-B12-D5 (Va), 16H12 (Vb) and 3G5-F7-G3 (VIc). One pair of strips was stained with Coomassie brilliant blue. 
Bands of interest are indicated by arrows. Migration of M r standards is indicated. 
Individual fibers were followed through the serial 
cross-sections and each staining was visually rated propor- 
tional to the intensity of its punctuate appearance, rather 
than more diffuse background, from 0 (no staining) to 4 
(most deeply stained), by two observers independently. 
3. Results 
3.1. Immunoblot  analysis 
Monoclonal antibodies against nuclear-encoded sub- 
units of cytochrome-c oxidase were raised against the 
bovine enzyme. To obtain monocional antibodies against 
the mitochondrially encoded subunits, the isolated subunits 
of human cytochrome-c oxidase were used. An overview 
of the monoclonal antibodies employed in this study is 
given in Table 1. 
We used immunoblot strips with total cellular protein 
from the human control cell line 143B. TK-  and its 
derivative cell line 143B206, which lacks mitochondrial 
DNA (p°  cells) [27], to test the (cross-)reaction and 
specificity of the monoclonal antibodies (Fig. 1). Of the 
two monoclonal antibodies raised against subunit I, one 
antibody (1D6-E1-A8) recognized a single band on the 
strip with control cell lysate, migrating slightly slower than 
the 43k marker, and showed no reaction on the strip with 
p0 cell lysate. The other antibody (5D4-F5) predominantly 
reacted with a band co-migrating with the only band 
recognized by 1D6-EI-A8 on the strip with control cell 
lysate. Monoclonal 5D4-F5 did not identify this band on 
the strip with p0 cell lysate. These results clearly indicate 
that both monoclonals recognize human cytochrome-c oxi- 
dase subunit I on immunoblots because both antibodies 
react with a band in control cells migrating slightly slower 
than the 43k marker (which is the position of subunit I) 
and neither antibody reacts with this band in cells lacking 
the gene for subunit I. However, the reaction of 1D6-EI-A8 
is more specific than that of 5D4-F5 on immunoblots. 
The monoclonal antibody raised against cytochrome-c 
oxidase subunit II (12C4-F12) reacted strongly with a 
single band on the strip with control cell lysate, migrating 
between the 29k and 14k markers (the position of subunit 
II), but failed to react with any protein band on the strip 
with p0 cell lysate (Fig. 1). This result clearly demon- 
strates the specificity of monoclonal 12C4-F12 for subunit 
II. 
Previous studies have revealed that monoclonal anti- 
body 10G8-D12-C 12, raised against bovine cytochrome-c 
Fig. 2. Sections of skeletal muscle of a patient with CPEO. (a) Serial cross-sections. Panels how: histochemical staining for myofibrillar actomyosin 
ATPase activity for fiber typing (ATP), histochemical staining for cytochrome-c oxidase activity (COX), and immunohistochemical staining with 
monoclonal ntibodies 5D4-F5 (I), 12C4-F12 (II), 10G8-C12-D12 (IV), 6E9-B12-D5 (Va), 16H12 (Vb) and 3G5-F7-G3 (VIc). Marked fibers are: type 1, 
normal cytochrome-c oxidase activity (A); type 1, reduced cytochrome-c oxidase activity (B); type 2b, reduced cytochrome-c oxidase activity (C); type 2b, 
no cytochrome-c oxidase activity (D); type 2a, normal cytochrome-c oxidase activity (E); type 2a, reduced cytochrome-c oxidase activity (F); type 2a, no 
cytochrome-c oxidase activity (G). (b) Longitudinal section histochemically stained for cytochrome-c oxidase activity. 
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oxidase subunit IV, cross-reacts with subunit IV from 
human and chicken [8,17]. Fig. 1 illustrates that this 
monoclonal specifically recognizes the human subunit in a 
lal 
203 
total cell lysate. Similar amounts of protein were loaded on 
the two gels with either control or p0 cell lysate, as 
indicated by the two strips stained with Coomassie brilliant 
Ibl 
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blue (Fig. 1). The signal of the anti-subunit IV monoclonal 
is only slightly less on the strips with p0 cell lysate 
compared to the strips with control cell lysate. Thus, 
despite the absence of mitochondrially encoded cy- 
tochrome-c oxidase subunits in p0 cells, subunit IV is 
present in almost normal amounts. 
The monoclonal antibodies against subunit Va (6E9- 
B 12-D5) and subunit Vb (16H 12) predominantly recognize 
one protein band on the strip with control cell lysate, 
migrating between the 14k and 6k markers (the position of 
subunits Va and Vb). The specificity of these monoclonals 
for either subunit Va or Vb was determined on highly 
resolving SDS-polyacrylamide gels with bovine cy- 
tochrome-c oxidase as detailed in Section 2. Whereas 
incubation of a p0 cell lysate strip with the anti-subunit 
Va monoclonal resulted in only a slight decrease in stain- 
ing, incubation with the anti-subunit Vb monoclonal re- 
sulted in a faint band compared to the predominant band 
on the control strip. Apparently, like subunit IV, subunit 
Va is present at almost normal steady-state l vels in p0 
cells. Steady-state l vels of subunit Vb, however, are 
severely decreased in cells devoid of mitochondrial DNA. 
Monoclonal antibody 3G5-F7-G3 was raised against 
bovine cytochrome-c oxidase. On immunoblots with the 
bovine enzyme, 3G5-F7-G3 reacted with a band that con- 
tains the closely migrating subunits VIb and VIc (not 
shown). The specificity of this monoclonal for subunit VIc 
was determined with bovine cytochrome-c oxidase prepa- 
rations in which subunit VIb was removed (see Section 2). 
Moreover, we have demonstrated that this monoclonal still 
recognizes a protein band with the correct M r of subunit 
VIc in enzyme preparations incubated with trypsin, which 
selectively digests the subunits Via and VIb [9]. Incubation 
of a human control cell lysate strip with monoclonal 
3G5-F7-G3 resulted in an intensely stained protein band 
co-migrating with the 6k marker (position of subunit VIc) 
and less intensely stained higher M r protein bands (Fig. 1). 
The same pattern of higher M r protein bands show up on 
the p0 cell lysate strip but the intensely stained lower M r 
protein band on the control strip is absent (Fig. 1). These 
results strongly suggest that the intensely stained lower M r 
protein band represents subunit VIc and that the amount of 
this subunit is greatly reduced in cells lacking mitochon- 
drially encoded subunits. 
3.2. Immunohis tochemica l  analysis  
To explore the use of the monoclonal antibodies in 
immunohistochemical studies, we applied the antibodies 
on serial skeletal muscle sections of a CPEO patient 
known to harbor the 'common deletion' in a subpopulation 
of her mitochondrial DNA. First, we followed 30 fibers on 
serial cross-sections of an age-matched control muscle 
specimen. Cytochrome-c oxidase activity was demon- 
strated in all control muscle fibers. The staining intensity 
indicated that the activity was relatively high in type 1 
(slow-twich, oxidative) fibers, followed by type 2b (fast- 
twitch, glycolytic) and type 2a (fast-twitch, oxidative-gly- 
colytic) fibers (not shown). Immunohistochemical detec- 
tion of individual subunits of cytochrome-c oxidase in 
control muscle with the monoclonal antibodies listed in 
Table 1 showed particulate staining in all fibers that was 
more pronounced in type 1 than in type 2a and 2b fibers 
(not shown). 
In the patient's specimen, 72 fibers were studied in 
serial cross-sections. One set of serial sections in which 
fibers were followed is shown in Fig. 2a. The myofibrillar 
actomyosin ATPase profile displayed the normal checker- 
board distribution of type 1 (dark), type 2b (intermediate) 
and type 2a (light) fibers (cf. Ref. [34]). Sections stained 
with modified Gomori trichrome revealed that less than 
1% of the fibers was ragged-red (not shown). Approxi- 
mately 30% of all fibers, including all ragged-red fibers, 
exhibited no cytochrome-c oxidase activity in cross-sec- 
tions. In longitudinal sections, some fibers showed virtu- 
ally no cytochrome-c oxidase activity but other fibers had 
normal activity or the enzyme defect was segmentally 
expressed (Fig. 2b). 
The immunohistochemical examination of serial cross- 
sections with the cytochrome-c oxidase subunit specific 
monoclonal antibodies revealed a scattered pattern of stain- 
ing (Fig. 2a). Staining intensities were visually rated from 
0 (no staining) to 4 (darkest staining) in all 72 fibers 
studied in cross-sections. The semi-quantitative data for 
type 1 fibers are compiled in Fig. 3, where they are 
subdivided into three categories: those with relatively nor- 
mal cytochrome-c oxidase activity, those with reduced 
cytochrome-c oxidase activity, and ragged-red fibers which 
had no apparent cytochrome-c oxidase activity. In type 1 
fibers with relatively high cytochrome-c oxidase activity 
levels (Fig. 2a, fiber A; Fig. 3a), immunodetectable pro- 
teins were mostly present at relatively high levels and no 
defects were found for succinate dehydrogenase. Type 1 
fibers with reduced cytochrome-c oxidase activity (Fig. 2a, 
fiber B; Fig. 3b) showed in general an associated loss of 
immunodetectable proteins and slightly reduced succinate 
dehydrogenase activity. Type 1 fibers virtually lacking 
cytochrome-c oxidase activity are not present in the sec- 
tion shown in Fig. 2a but all were ragged-red and showed 
high levels of succinate dehydrogenase activity (Fig. 3c). 
In these cytochrome-c oxidase activity negative fibers, the 
cytochrome-c oxidase subunits I, II, Va, Vb and VIc were 
undetectable with the monoclonals in some fibers but low 
levels were demonstrated in other fibers. Immunodetection 
with the monoclonal against subunit IV, however, resulted 
in intense staining of all ragged-red fibers. 
The correlation between enzyme activities and immuno- 
detectable proteins in type 2a and type 2b fibers (Fig. 2a, 
fibers C-G) followed the same trend as described for type 
1 fibers. Of the 25 type 2a fibers studied, none of the 12 
fibers lacking cytochrome-c oxidase activity was ragged- 
red, whereas of the 16 type 2b fibers studied, only 1 of the 
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Fig. 3. Correlation between cytochrome-c oxidase activity and immuno- 
detectable cytochrome-c oxidase subunits in type 1 muscle fibers of a 
CPEO patient. Fibers are classified according to cytochrome-c oxidase 
activity (normal activity, panel A; reduced activity, panel B; no activity, 
panel C). Bars indicate mean of staining intensity for: cytochrorne-c 
oxidase activity (COX), immunodetectable cytochrome-c oxidase subunit 
I (I), subunit II (II), subunit IV (IV), subunit Va (Va), subunit Vb (Vb) 
and subunit VIc (VIc), and succinate dehydrogenase activity (SDH). 
Standard deviations of mean values are indicated. All cytochrome-c 
oxidase activity negative fibers (i.e., all fibers in panel C) were ragged-red 
with Gomori trichrome stain. 
5 fibers lacking cytochrome-c oxidase activity was ragged- 
red and had relatively high succinate dehydrogenase activ- 
ity. In cytochrome-c oxidase activity negative type 2a and 
2b fibers, subunit II, Vb and VIc of cytochrome-c oxidase 
could not be demonstrated with the antibodies. The sub- 
units I and Va, however, were still demonstrated in some 
of these fibers, though at reduced levels. In these cy- 
tochrome-c oxidase activity negative fibers, steady-state 
levels of subunit IV did not differ significantly from fibers 
with apparently normal cytochrome-c oxidase activity. The 
single type 2b ragged-red fiber lacked immunodetectable 
subunits I, II, Va, Vb, and VIc, but subunit IV was 
demonstrated to be present at a steady-state l vel higher 
than in type 2b fibers with apparently normal cytochrome-c 
oxidase activity. 
4. Discussion 
Antibodies have been used by others to investigate 
cytochrome-c oxidase deficiencies at the protein level. In 
early studies, antisera gainst he holo-enzyme were used 
(e.g., Refs. [35-39]). More recently, either subunit specific 
polyclonal [39-46] and/or monoclonal antibodies [47-55] 
were employed. However, many of these 'subunit specific' 
antibodies, including monoclonal antibodies, recognize ap- 
parent clusters of subunits that are difficult to resolve on 
SDS-polyacrylamide g ls, such as subunits Va and Vb, or 
subunits Via, VIb and VIc [40-50]. Thus, accurate identi- 
fication of the cytochrome-c oxidase subunits has not been 
possible. We have developed a battery of truly subunit 
specific monoclonal antibodies which permit a more de- 
tailed analysis of the mutant enzyme. When applied on 
immunoblots with whole cell extracts, most of the mono- 
clonal antibodies listed in Table 1 exclusively react with 
their respective subunit (Fig. l), illustrating the high speci- 
ficity of these monoclonals. One of the monoclonals against 
subunit I (5D4-F5) and the monoclonal against subunit VIc 
also bind to some extent to other proteins on the im- 
munoblot strips with total cellular protein (Fig. 1) but the 
cytochrome-c oxidase subunit can still easily be identified. 
Thus, the subunit steady-state l vels can be determined in
crude cell and tissue extracts. 
In the experimental human cell line 143B206, which is 
devoid of mitochondrial DNA, the monoclonal antibodies 
reveal that the nuclear-encoded cytochrome-c oxidase sub- 
units IV and Va are present in amounts close to those of 
the parental cell line, whereas the amounts of the nuclear- 
encoded subunits Vb and Vlc are severely reduced (Fig. 
1). Similar results have been obtained with a myoblast cell 
line from a patient with mitochondrial DNA depletion 
syndrome (J.-W. Taanman, J.M. Cooper and A.H.V. 
Schapira, unpublished observations). In the CPEO patient, 
most cytochrome-c oxidase activity negative fibers have 
greatly reduced levels of subunit I, II, Va, Vb, and VIc of 
cytochrome-c oxidase (Figs. 2 and 3). The steady-state 
levels of subunit IV, however, were less affected. Particu- 
larly in fibers with accumulated mitochondria (ragged-red), 
immunostaining with anti-subunit IV resulted in high sig- 
nals. In yeast null mutants for subunit 1 or II of cy- 
tochrome-c oxidase, we also observed ifferential steady- 
state levels of the nuclear-encoded subunits, with 50-100% 
remaining of the yeast homologs for the (mammalian) 
subunits IV and Va, and 20-30% remaining of the yeast 
homolog for subunit Vb (L.F.M. Calavetta, J.-W. Taanman 
and R.A. Capaldi, unpublished observations). 
Recently, Nijtmans and colleagues [56] reported that the 
steady-state l vels of all nuclear-encoded subunits of cy- 
tochrome-c oxidase are without exception severely reduced 
by increased proteolytic degradation i human Molt-4 cells 
depleted of mitochondrial gene products. In contrast, our 
results indicate that some nuclear-encoded subunits are 
more stable than others in the absence of their mitochon- 
drially encoded partners. This is particularly evident in 
ragged-red fibers where increased amounts of subunit IV 
were demonstrated. These findings are corroborated by 
other immunohistochemical studies with subunit IV spe- 
cific antibodies [51-53]. Moreover, subunit IV remained at 
almost normal steady-state levels during inhibition of mito- 
chondrial protein synthesis in human HepG2 cells [57]. 
The function of most nuclear-encoded subunits of cy- 
tochrome-c oxidase is obscure and it cannot be excluded 
that some have an additional function besides their role in 
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the oxidase. Deletion analyses of nuclear genes coding for 
mitochondrial proteins have revealed a mosaic of cis-acting 
upstream and intron sequence lements required for maxi- 
mal transcription [58]. For instance, a recognition sequence 
for the transcriptional ctivator NRF-1 [59] has been iden- 
tified in the upstream regions of a large number of genes 
for mitochondrial proteins, including cytochrome-c oxi- 
dase subunit Vb [60] and VIc [61] but could not be 
demonstrated in the gene for subunit IV [62]. The apparent 
differential regulation of subunit IV gene transcription 
supports the idea of an additional function of subunit IV 
and may explain the relatively high steady-state l vels of 
this subunit in cells lacking cytochrome-c oxidase activity. 
In the immunohistochemical analysis of skeletal muscle 
of a patient with CPEO, occasional discrepancies were 
observed in the serial cross-sections where decreased im- 
munoreactivity was accompanied by normal cytochrome-c 
oxidase activity or the other way around. For instance, 
fiber 'E' in Fig. 2a shows normal cytochrome-c oxidase 
activity despite severly reduced levels of immunodetect- 
able subunit I. These anomalous ituations are probably 
due to the segmental nature of the pathology as demon- 
strated in a longitudinal section stained for cytochrome-c 
oxidase activity (Fig. 2b). Overall, the immunohistochemi- 
cal analysis clearly demonstrates that the focal defect of 
cytochrome-c oxidase activity in muscle of CPEO patients, 
as observed in this study and in other eports [39,41,49,63], 
is based on a nearly complete loss of the mitochondrially 
encoded subunits I and II and some nuclear-encoded sub- 
units of the enzyme complex. The loss of subunits I and II 
may be the result of a global mitochondrial translation 
failure, due to limiting amounts of some indispensable 
tRNAs whose genes are included in the 5-kb deletion. 
Alternatively, the loss of subunits I and II may be caused 
by increased proteolytic degradation because assembly does 
not occur in absence of subunit III whose gene is in the 
deleted region and may be present at restrictive copy 
numbers. 
The results presented in this paper demonstrate hat our 
panel of monoclonal antibodies can be used for diagnostic 
purposes to reveal steady-state l vels of mitochondrially 
and nuclear-encoded cytochrome-c oxidase subunits. To 
date, deficiency of the cytochrome-c oxidase is in general 
determined by analysis of the enzyme activity but this does 
not reveal the underlying defect. It would be of particular 
interest to know whether the disease is caused by a nuclear 
or mitochondrial mutation. We are currently investigating 
cell lines from other cases with cytochrome-c oxidase 
deficiency to classify patients by steady-state subunit pat- 
terns and try to correlate this with the genetic origin of the 
defect. 
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